Loading organizations...
Key people at Wyss Center for Bio and Neuroengineering.
The Wyss Center for Bio and Neuroengineering is a translational research center advancing disruptive neurotechnologies. It develops novel devices and therapies through pioneering approaches in neuroengineering, neuroAI, neuromodulation, and neuroimaging. The center addresses critical unmet medical needs for conditions like epilepsy, Alzheimer’s disease, and locked-in syndrome, converting scientific discoveries into clinical applications.
Established in 2014, the Wyss Center was founded by entrepreneur and philanthropist Hansjörg Wyss. His generous donation and commitment to scientific progress provided the impetus for this not-for-profit organization. The core insight was to bridge groundbreaking academic research with the practical development of neurotechnology.
The center serves individuals afflicted by severe neurologic and mental health disorders. Collaborating with academic, clinical, and industrial partners, it accelerates technology development and market entry. The Wyss Center’s vision is to enable every person with these disorders to live life to their fullest, striving to deliver transformative solutions.
Key people at Wyss Center for Bio and Neuroengineering.
Wyss Center for Bio and Neuroengineering has 1 tracked investment across 1 company. The latest tracked deal is $6.6M Debt / Series A in ARTIRIA Medical in February 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 27, 2024 | ARTIRIA Medical | $6.6M Debt / Series A | Valentin Maxime Chenaux | Foundation For Technological Innovation, Nest Sammelstiftung, Verve Ventures, Zürcher Kantonalbank |